Finance

Lists
002550:SHE
Changzhou Qianhong Biopharma Co Ltd
CNÂ¥6.62
+1.22%
(+0.080) 1D
Sep 8, 3:04:09 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002550...
Open
CNÂ¥6.54
High
CNÂ¥6.66
Low
CNÂ¥6.51
Mkt. cap
8.40B
Avg. vol.
26.05M
Volume
10.78M
Dividend
2.27%
Quarterly dividend
CNÂ¥0.04
Ex-dividend date
May 29, 2026
P/E ratio
28.26
52-wk high
CNÂ¥10.30
52-wk low
CNÂ¥5.58
EPS
CNÂ¥0.23
Shares outstanding
1.28B
No. of employees
1K
Open
CNÂ¥6.54
High
CNÂ¥6.66
Low
CNÂ¥6.51
Mkt. cap
8.40B
Avg. vol.
26.05M
Volume
10.78M
Dividend
2.27%
Quarterly dividend
CNÂ¥0.04
Ex-dividend date
May 29, 2026
P/E ratio
28.26
52-wk high
CNÂ¥10.30
52-wk low
CNÂ¥5.58
EPS
CNÂ¥0.23
Shares outstanding
1.28B
No. of employees
1K
About Changzhou Qianhong Biopharma Co Ltd
CEO-
Employees1.04K
Founded1971
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
353.24M
356.26M
358.08M
400.29M
Cost of goods sold
137.30M
151.56M
139.36M
215.12M
Cost of revenue
137.30M
151.56M
139.36M
215.12M
Research and development expenses
26.02M
40.80M
20.49M
22.72M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
109.16M
144.09M
92.04M
97.78M
Operating expense
12.39M
308.71M
112.00M
126.51M
Total operating expenses
149.69M
460.27M
251.36M
341.63M
Operating income
203.55M
-104.01M
106.72M
58.66M
Other non operating income
-63.16M
121.49M
-10.32M
10.51M
EBT including unusual items
144.70M
12.38M
102.80M
64.53M
EBT excluding unusual items
148.88M
8.02M
99.47M
58.06M
Income tax expense
26.15M
7.26M
18.30M
6.15M
Effective tax rate
18.07%
58.64%
17.80%
9.53%
Other operating expenses
-3.03M
8.75M
-756.78K
5.91M
Net income
125.18M
15.57M
85.06M
67.77M
Net profit margin
35.44%
4.37%
23.75%
16.93%
Earnings per share
-
-
-
-
Interest and investment income
6.52M
4.69M
3.08M
7.14M
Interest expense
-254.74K
-22.87K
-
-97.81K
Net interest expenses
6.26M
4.66M
3.08M
7.04M
Depreciation and amortization charges
-
-
-
-
EBITDA
219.70M
-87.82M
122.91M
75.56M
Gain or loss from assets sale
-
-14.36K
-
-
AI content may include mistakes. Learn more
Google apps